HIV/AIDS Clinical Trials in Chicago

Showing 61-80 of 641 trials

Observational Study of HIV+ Deceased Donor Transplant for HIV+ Recipients

NCT02602262

HIV-infected (HIV+) individuals who agree to accept and receive a solid organ transplant from an HIV+ deceased donor will be followed to determine the safety and efficacy of this practice. Some HIV+ individuals who receive a solid organ transplant from HIV-uninfected (HIV-) donors will also be followed.

HIV Infection

Johns Hopkins University105 participantsStarted Nov 2015

Aurora, Colorado, United States • New Haven, Connecticut, United States • Washington D.C., District of Columbia, United States +15 more locations

COMPLETED2.2 miles

Increasing PrEP Awareness and Demand Among Black Cisgender Women

NCT05896423

This study will develop HIV pre-exposure prophylaxis (PrEP) awareness materials for and with Black cis women and gather feedback on the usefulness of these materials at health care sites. The investigators will also use electronic medical records (EMR) to compare the number of Black cis women who initiate PrEP before and after the awareness materials are piloted, at the two partner research sites, Howard Brown Health and Planned Parenthood of IL. Additional federally qualified health centers and family planning clinics will review the materials and complete a survey on acceptability.

HIVPrEP

Northwestern University30 participantsStarted Aug 2023

Chicago, Illinois, United States • Chicago, Illinois, United States

Observational Study of HIV+ Deceased Donor Transplant for HIV+ Recipients

Increasing PrEP Awareness and Demand Among Black Cisgender Women

HIV/AIDS Trials in Other Cities

A Hybrid Type II Trial of the Optimizing Resilience and Coping With HIV Through Internet Delivery in Ryan White Clinics in Chicago

VGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal Lesions

Case Management Dyad

Adolescent Master Protocol

Adolescent Master Protocol for Participants 18 Years of Age or Older - Lite

Safety, Tolerability and Acceptability of Long-Acting Cabotegravir (CAB LA) for the Prevention of HIV Among Adolescent Males

Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK)

Development of a Health-Related Symptom Index for Participants With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions

P-CHAT: Comparison of Direct to Consumer Delivery Models for Hearing Devices

A Study to Evaluate the Anti-inflammatory Effects of Letermovir (Prevymis) in Adults With Human Immunodeficiency Virus (HIV)-1 and Asymptomatic Cytomegalovirus (CMV) Who Are on Suppressive Antiretroviral Therapy, Plus Its Effect on Chronic Inflammation, HIV Persistence and Other Clinical Outcomes.

Study to Evaluate the Safety and Efficacy of Teropavimab and Zinlirvimab in Combination With Lenacapavir in Virologically Suppressed Adults With HIV-1 Infection

Study Using CABENUVA™ for the Treatment of Human Immunodeficiency Virus (HIV)-1, Administered in Infusion Centers (IC) or Alternate Sites of Administration (ASA) in the United States (U.S.)

Long Term Follow-up of HPV Vaccine in HIV (CTN 236)

Predictive Analytics and Clinical Decision Support to Improve PrEP Prescribing

High-quality COPD Care for People With Immune Dysfunction Through Proactive E-consults

Integrated e-Health (Electronic Health) for HIV and Substance Use Disorders in Justice Involved Women

Alcohol Research Consortium in HIV-Intervention Research Arm

Intervention to Enhance PrEP Persistence

Other Conditions in Chicago